Canada markets close in 3 hours 58 minutes

ReShape Lifesciences Inc. (RSLS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.1644+0.0022 (+1.37%)
As of 12:01PM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
8,678
8,678
11,240
13,600
11,299
Cost of Revenue
3,130
3,130
4,438
5,252
5,037
Gross Profit
5,548
5,548
6,802
8,348
6,262
Operating Expenses
Research Development
2,315
2,315
2,537
2,369
3,498
Selling General and Administrative
17,872
17,872
31,343
33,212
15,221
Total Operating Expenses
20,187
20,187
33,880
35,581
18,719
Operating Income or Loss
-14,639
-14,639
-27,078
-27,233
-12,457
Interest Expense
-
-
113
832
2,049
Total Other Income/Expenses Net
3,278
3,278
-19,403
-35,355
-7,305
Income Before Tax
-11,335
-11,335
-46,594
-63,420
-21,811
Income Tax Expense
52
52
-380
-274
-181
Income from Continuing Operations
-11,387
-11,387
-46,214
-63,146
-21,630
Net Income
-11,387
-11,387
-46,214
-63,146
-21,630
Net Income available to common shareholders
-11,387
-11,387
-46,214
-63,146
-21,630
Basic EPS
-38.56
-1.91
-108.90
-288.97
-277.00
Diluted EPS
-38.56
-1.91
-108.90
-288.97
-277.00
Basic Average Shares
2,229
5,957
424.39
218.522
78.095
Diluted Average Shares
2,229
5,957
424.39
218.522
78.095